LOC728373 Activators
LOC728373 activators pertain to a category of chemical agents that target and modulate the activity of a genetic element designated as LOC728373. This genetic element, classified within the vast lexicon of human DNA, is an enigmatic sequence whose functional attributes are not thoroughly delineated within the scope of current scientific understanding. The activators influencing LOC728373 are therefore of notable interest within the biochemical and molecular biology fields for their ability to engage with and potentially alter the expression or activity of this particular genetic sequence. The study of such activators often involves the exploration of their molecular structure, the mechanisms through which they interact with LOC728373, and the subsequent biochemical pathways that may be affected as a consequence of this interaction.
The chemical structure of LOC728373 activators can vary widely, encompassing a spectrum of small molecules, organic compounds, or larger biomolecules that possess the specific binding affinity towards the LOC728373 sequence or its associated regulatory proteins. These activators may be discovered through high-throughput screening methods or serendipitous scientific observations. Delving into the molecular mechanics, these activators may function by binding directly to the DNA sequence of LOC728373, altering its conformation and thus influencing its interaction with transcriptional machinery. Alternatively, they might exert their effects indirectly by modulating the activity of proteins that regulate LOC728373, thereby affecting its transcriptional or translational output. Understanding the precise mode of action of these activators is often a complex endeavor, as it involves dissecting the intricacies of gene regulation, protein-DNA interactions, and the cellular context within which LOC728373 operates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate binds to its G protein-coupled receptors, initiating a signaling cascade that can lead to the activation of phosphatases, potentially resulting in an environment that supports the deubiquitination activity of LOC728373. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. By inhibiting certain kinases, it may lead to reduced phosphorylation of proteins that are substrates for LOC728373, thus enhancing LOC728373's functional role in protein deubiquitination. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent phosphatases. These phosphatases may dephosphorylate regulatory proteins that interact with or modify LOC728373 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to downstream effects that may include the enhancement of LOC728373 activity by altering the phosphorylation state of proteins within its regulatory network. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can increase the activity of certain deubiquitinating enzymes by altering signaling pathways where PI3K is a key node, potentially leading to enhanced activity of LOC728373. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these phosphatases could lead to an accumulation of phosphorylated proteins, which could be preferential substrates for LOC728373's deubiquitination activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDAC). HDAC inhibition can result in an altered gene expression profile that may upregulate proteins that interact with or regulate LOC728373, potentially enhancing its activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins. This accumulation might enhance the functional activity of LOC728373 by increasing the number of substrates available for deubiquitination. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is an HDAC inhibitor, which, similarly to TSA, can alter gene expression profiles and potentially increase the expression of proteins that interact with LOC728373, enhancing its deubiquitinating activity. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG is an HSP90 inhibitor that can lead to the degradation of its client proteins. This may cause a compensatory upregulation of deubiquitinating enzymes such as LOC728373 to restore protein homeostasis. | ||||||